Market Research Logo

Axxam SpA - Product Pipeline Review - 2015

Axxam SpA - Product Pipeline Review - 2015


Global Markets Direct’s, ‘Axxam SpA - Product Pipeline Review - 2015’, provides an overview of the Axxam SpA’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Axxam SpA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Axxam SpA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Axxam SpA’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Axxam SpA’s pipeline products
Reasons to buy
  • Evaluate Axxam SpA’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Axxam SpA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Axxam SpA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Axxam SpA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Axxam SpA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Axxam SpA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Axxam SpA Snapshot
Axxam SpA Overview
Key Information
Key Facts
Axxam SpA - Research and Development Overview
Key Therapeutic Areas
Axxam SpA - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Axxam SpA - Pipeline Products Glance
Axxam SpA - Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Axxam SpA - Drug Profiles
Small Molecules to Agonize CN2 Receptor for Pain
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Antagonize BDKRB1 for Pain and Ophthalmic Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Block Kv1.3 for CNS, Immunology, Gastrointestinal and Metabolic Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Block P2RX7 for CNS and Autoimmune Disorders
Product Description
Mechanism of Action
R&D Progress
Axxam SpA - Pipeline Analysis
Axxam SpA - Pipeline Products by Target
Axxam SpA - Pipeline Products by Molecule Type
Axxam SpA - Pipeline Products by Mechanism of Action
Axxam SpA - Dormant Projects
Axxam SpA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
List of Tables
Axxam SpA, Key Information
Axxam SpA, Key Facts
Axxam SpA - Pipeline by Indication, 2015
Axxam SpA - Pipeline by Stage of Development, 2015
Axxam SpA - Monotherapy Products in Pipeline, 2015
Axxam SpA - Discovery, 2015
Axxam SpA - Pipeline by Target, 2015
Axxam SpA - Pipeline by Molecule Type, 2015
Axxam SpA - Pipeline Products by Mechanism of Action, 2015
Axxam SpA - Dormant Developmental Projects,2015
Axxam SpA, Other Locations
List of Figures
Axxam SpA - Pipeline by Top 10 Indication, 2015
Axxam SpA - Pipeline by Top 10 Target, 2015
Axxam SpA - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report